Theocharis Koufakis

Assitant Professor in Internal Medicine

Aristotle University of Thessaloniki

Greece

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Theocharis Koufakis is an Assistant Professor in Internal Medicine at Aristotle University of Thessaloniki, Greece. His research focuses on various aspects of internal medicine, including the management of diabetes, cardiovascular diseases, and the implications of inflammatory markers in health. Recent publications highlight the establishment of integrated clinical centers for diabetes management, the relationship between vitamin D and cardiovascular health, and the emerging concerns surrounding pathogens in hospitalized patients.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (8)

Kalliopi Kotsa

Professor in Endocrinology-Diabetes

Aristotle University of Thessaloniki

GREECE

View details

Spyridon Karras

GREECE

View details

Nikolaos Papanas

Democritus University of Thrace

GREECE

View details

Areti Kourti

Aristotle University of Thessaloniki

GREECE

View details

Luca Busetto

University of Padova

ITALY

View details

Kali Makedou

Associate Professor

Aristotle University of Thessaloniki

GREECE

View details

Vassiliki N Michou

Adjusted Lecturer

University of Western Macedonia

GREECE

View details

Pantelis Zebekakis

Professor

Aristotle University of Thessaloniki

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Theocharis Koufakis

Research Interests

Contact this professor

About

Articles (20)

Rationale for the establishment of a national integrated adult type 1 diabetes clinical center in a Mediterranean country: real-world experience and associated costs

Duration of vitamin D supplementation modulates the association between cardiovascular disease and high-sensitivity C-reactive protein across body mass index strata

Interleukin-6-Related Inflammatory Burden in Type 1 Diabetes: Evidence for Elevation with Suboptimal Glycemic Control

Dual incretin agonism and the gut microbiome: does the heart of metabolic regulation beat in the gut?

Epidemiological and Clinical Characteristics of Stenotrophomonas maltophilia Isolates from Hospitalized Medical Patients; An Emerging Pathogen in the Non-Critically Ill

Definition, Classification, Diagnosis, and Management of an Emerging Threat: Cardio-Renal-Metabolic Syndrome

Divergent Interleukin-6 Responses to Hypoglycemia and Hyperglycemia in Adults With Type 1 Diabetes: Insights From Continuous Glucose Monitoring

Efficacy of Biologic Agents and Small Molecules for Endoscopic Improvement and Mucosal Healing in Patients with Moderate-to-Severe Ulcerative Colitis: Systematic Review and Meta-Analysis

CONFIDENCE in the safety and efficacy of dual therapy with an SGLT‐2 inhibitor and finerenone in patients with chronic kidney disease and type 2 diabetes

And the Dog Was Barking: Transforming Quality of Life in Diabetes Through Innovative Hypoglycemia Detection

Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes

Should tirzepatide be considered for early management in type 2 diabetes? Pros and cons

Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?

The effects of sodium-glucose cotransporter 2 inhibitors beyond the cardio-renal-metabolic spectrum: will gliflozins have a different fate than statins?

The Recent Trends in All-cause and Cardiovascular Mortality among People with Type 1 Diabetes Mellitus - Success is Still Far Away, and We Must Do Better!

Changes in the Global Epidemiology of Type 1 Diabetes in an Evolving Landscape of Environmental Factors: Causes, Challenges, and Opportunities

Different patterns of changes in free 25-hydroxyvitamin D concentrations during intermittent fasting among meat eaters and non-meat eaters and correlations with amino acid intake

Changes in dietary intake of aspartic acid during and after intermittent fasting correlate with an improvement in fasting glucose in overweight individuals

Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attention

Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches

Collaborators (8)

Kalliopi Kotsa

Spyridon Karras

Nikolaos Papanas

Areti Kourti

Luca Busetto

Kali Makedou

Vassiliki N Michou

Pantelis Zebekakis

Make your next move.